EP4373551A1 - Dispositif d'actionnement amélioré pour stylo injecteur - Google Patents
Dispositif d'actionnement amélioré pour stylo injecteurInfo
- Publication number
- EP4373551A1 EP4373551A1 EP22730232.0A EP22730232A EP4373551A1 EP 4373551 A1 EP4373551 A1 EP 4373551A1 EP 22730232 A EP22730232 A EP 22730232A EP 4373551 A1 EP4373551 A1 EP 4373551A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- magnetic field
- sensor
- actuating device
- magnetic
- angle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011156 evaluation Methods 0.000 claims abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 24
- 238000007911 parenteral administration Methods 0.000 claims abstract description 9
- 230000008859 change Effects 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 15
- 230000005415 magnetization Effects 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000011161 development Methods 0.000 description 16
- 230000018109 developmental process Effects 0.000 description 16
- 238000002347 injection Methods 0.000 description 15
- 239000007924 injection Substances 0.000 description 15
- 238000005070 sampling Methods 0.000 description 15
- 238000012377 drug delivery Methods 0.000 description 7
- 230000004907 flux Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 238000005265 energy consumption Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012907 medicinal substance Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910000859 α-Fe Inorganic materials 0.000 description 2
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 108700021021 mRNA Vaccine Proteins 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
- A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button
Definitions
- the invention relates to devices, systems and methods for the reliable and accurate acquisition and evaluation of data in connection with the user-friendly and safe dosing and administration of medication.
- the disclosure of the present invention relates primarily to
- Delivery devices which have a threaded piston rod which can be advanced by a rotary drive. Such administration devices are used, for example, for the treatment of diabetes by administration of insulin.
- WO2018/160425 A1 describes a module or a system for recording the administered doses of a drug using a pen.
- the disclosure relates to a dose detection system for use in combination with a drug delivery device.
- the system includes a module that interfaces with the device and includes a sensor capable of sensing the relative angular position of an element attached to the drug delivery device.
- the system determines the type of medication contained in the device and/or the type of device based on the sensed angular position of the sensed element.
- the dose detection system is used in combination with a drug delivery device that includes a dose adjuster that rotates relative to an actuator during dose delivery.
- the dose detection system includes a sensor and is capable of sensing the relative angular positions of a sensed element attached to the dose setting element during dose delivery and determining the amount of dose delivered. Related methods are also disclosed. A quantitative determination of the administered dose is carried out using several sensors and a magnetic ring, which moves relative to the sensors during administration. There is no capture on this system during dose preselection.
- WO2019/001919 A1 describes an attachment which is suitable for being releasably attached to a drug delivery device, the attachment being suitable for this when attached to a housing of the drug delivery device, to determine an amount of movement of an indicator element, the accessory device comprising a type identifier adapted to detect a predefined type identifier on the drug delivery device.
- the accessory device is further configured to be activated from an initial inoperative state to a permanent operative state corresponding to a predefined condition, where the predefined condition corresponds to an identified predefined type identifier. With this additional device, no recording takes place during the dose preselection.
- WO2019/170429 shows a drug delivery system comprising: an elongate housing containing adjustment structure for adjusting a dose of drug via an angular position; and a sensor structure for determining dose, including a magnet and a magnetic sensor arranged so that at least one of an angular position and a displacement of the magnetic sensor relative to the magnet can be determined as a function of the electrical resistance of the magnetic sensor .
- the sensor structure is arranged with respect to the adjustment structure such that the angular position of the adjustment structure is determined as a function of the angular position and/or displacement of the magnetic sensor.
- a sensor structure comprising: a flexible foil having a magnetic sensor in a cylindrical shape configuration comprising an axis; and a magnet positioned on a line parallel to or collinear with the axis.
- the sensor structures disclosed are based on the magnetoresistive effect and are mere alternatives to optical or potentiometric measuring arrangements where changes in resistance are evaluated in analog form or interpolated. It remains open how to differentiate between displacement and rotation or how to ensure error-free results.
- a medicament in the present context includes any flowable medicinal formulation which is suitable for controlled administration by means of a cannula or hollow needle into subcutaneous or intramuscular tissue, for example a liquid, a solution, a gel or a fine suspension containing one or more active medicinal ingredients.
- a medicament may be a single active ingredient composition or a premixed or co-formulated multiple active ingredient composition from a single container.
- medicines such as peptides (e.g.
- insulins insulins, insulin-containing medicines, GLP 1-containing and derived or analogous preparations
- proteins and hormones proteins and hormones
- biologically derived or active substances substances based on hormones or genes, nutritional formulations, enzymes and other substances in solid (suspended) or liquid form.
- the term also includes polysaccharides, vaccines, DNA or RNA or oligonucleotides, antibodies or parts of antibodies as well as suitable base materials, auxiliary materials and carriers.
- distal refers to a side or direction directed toward the front, puncture-side end of the administration device or toward the tip of the injection needle.
- proximal designates a side or direction directed toward the rear end of the administering device opposite the end on the puncture side.
- injection system or “injector” mean a device in which the injection needle is removed from the tissue after a controlled amount of the medicinal substance has been released.
- injection needle in an injection system or in an injector does not remain in the tissue for a longer period of several hours.
- the object is achieved by an actuating device for an administering device for parenteral administration of a medicament according to claim 1.
- An administration device for parenteral administration of a medicament in particular an AutoPen or an injection device, as is the basis of the present invention, has various mechanical devices such as a dosing and a dispensing device, which are made up of several elements.
- a piston rod e.g. in the form of a threaded rod with a flange
- a drive movement can be effected manually, for example via a screw drive or by a motor, in particular a spring motor.
- An administration device for parenteral administration of a medicament can have an actuating device according to the invention.
- the product to be administered is, for example, a sleeve-shaped or cylindrical rotary element with an axis, which rotary element can be rotated relative to the device housing and coaxially about the longitudinal axis of the injection device by an angle proportional to the preselected and/or dispensed dose volume.
- the rotary element can, for example, be rotated from the outside via a rotary knob and can be coupled to the spring motor in such a way that it can be tensioned via the rotation and/or the rotary element participates in the drive movement.
- a pusher element can be provided which can be actuated from the outside, for example via a push button, and can be moved along the longitudinal axis of the injection device relative to the device housing, which acts on the motor or a clutch and triggers or releases or blocks the drive movement.
- the thrust element can rotatably and axially fixedly support the rotary element, with the latter participating in the thrust movement.
- the pushing element and the rotating element can be made in one piece and be mounted in the injection device in such a way that it can both rotate relative to the device housing and move along the longitudinal axis.
- the thrust element can be mounted in the device housing so that it can be displaced collinearly or coaxially to the longitudinal axis, independently of the rotary element.
- the thrust element can be moved axially relative to the rotary element and can be rotationally coupled to the rotary element.
- the thrust element can perform a linear, in particular axially directed, change in position, with the change in position being able to be limited by axial end stops.
- the thrust element can be actuated against an axially acting spring force of a restoring spring, which can move it back into an initial position.
- the rotating element changes the angle, the maximum possible change in angle being able to be limited, for example, by radial end stops.
- the rotary element can be operatively connected to a latching device which can hold the rotary element in a non-positive manner in predetermined, in particular regularly distributed, latching positions or angles of rotation.
- this latching device can be implemented by an elastic snapper in the form of a ratchet or by a click disk subjected to spring force.
- a measuring device is provided on the actuating device according to the invention, which has a magnetic element with permanent magnetization, in particular a hollow-cylindrical or toroidal magnetic element, for example in the form of a hollow shaft.
- the magnetic element can be magnetized alternately in sectors, in particular evenly distributed, so that the pole angles are all of the same size with respect to an axis of rotation.
- the permanent magnetization of each sector can be directed radially, with an N or S pole being formed on the outer shell surfaces and the associated inner shell surfaces of the hollow cylinder sectors. The same applies to the end faces pointing in the axial direction of the hollow cylinder sectors are each formed in areas of the N and S poles.
- the magnetization can also take place as a so-called Halbach array, with the advantage that the magnetic flux on the inside of the magnetic element is almost eliminated and is correspondingly strengthened on the outside.
- the axis of rotation of the magnetic element can advantageously coincide with the longitudinal axis of the injection device and/or the axis of the rotary element.
- the magnetic element can have 10 poles or sectors or pole angles distributed over the circumference as a ring magnet, with an N- on a regular distribution every 36° follows an S pole. More or fewer poles can also be provided, preferably 2 to 40 or more.
- the magnetic element can be operatively connected to the rotating element and/or the pushing element in such a way that it follows the latter's movements relative in particular to the device housing.
- the magnetic element is mounted coaxially on the rotary element in a rotationally fixed manner and is axially fixed but rotatably connected to the thrust element, or the magnetic element is firmly connected to the thrust element, which participates in the rotary movement of the rotary element.
- the magnetic element can be positively connected to the rotating element or the pushing element, for example by means of ribs and grooves. Due to the magnetization, there is a magnetic field of different strength and direction in the space above the outer surface of the magnetic element.
- an alternately polarized flux density or field component forms with a maximum centered above the axial pole boundaries.
- an alternately polarized flux density or field component forms with a maximum in each case over the proximal and distal end faces.
- the latching device can also work magnetically, with at least one suitably shaped and magnetized and/or magnetizable stator connected non-rotatably to the device housing being able to move and hold the magnetic element or the rotating element non-rotatably connected to it into the latching positions by magnetic forces.
- These latching positions or the angles of rotation between the latching positions of the rotary element can correspond to predetermined dose steps of the medication to be administered.
- a magnetically working latching device for an actuation or administration device for parenteral administration of a drug can have the following designs for a stator element in addition to a magnet element that can be rotated relative to the device housing:
- a magnet fixed to the housing shaped as a full or partial ring, having a sector-wise identical or complementary magnet Permanent magnetization like the magnetic element, preferably acting proximally or distally on the end face or radially or circumferentially via an air gap on the magnetic element.
- Such an arrangement snaps by double pole resp. sector angle.
- Such a stator element can preferably be designed, for example, as a U-shaped yoke made of soft-magnetic material, which makes it possible to connect two different poles of the magnetic element.
- Such soft magnetic arrangements snap by simple pole resp. sector angle.
- the measuring device on the actuating device has a sensor arrangement which consists of at least three magnetic field sensors.
- Each of these magnetic field sensors has a pronounced sensitivity or directional effect with regard to the direction and/or polarization of the magnetic field relative to a sensor axis referred to as the switching axis.
- a digital output with memory or latch of each magnetic field sensor is switched on or set when an N to S polarized flux density along the switching axis reaches or exceeds a switch-on value and switched off or reset when an S to N polarized flux density reaches or exceeds a switch-off value.
- the magnetic field sensors preferably have an integrated arrangement which works according to the magnetoresistive principle, particularly preferably according to the tunnel magnetoresistive principle. Such components are also known as TMR sensors.
- TMR sensors Due to their high sensitivity with regard to the magnetic field strength, TMR sensors offer advantages with regard to energy consumption and with regard to the degree of freedom in the structural arrangement of the elements of the actuating device according to the invention. Thanks to the high sensitivity of the TMR sensors, there is no need for rare earth magnets and inexpensive, corrosion-resistant materials can be used for the magnetic element, such as ferrites.
- the sensor arrangement is or can be connected to an evaluation device, in particular a computer or software-implemented evaluation device, for example a circuit having a microcontroller and/or a Field Programmable Gate Array FPGA.
- the outputs of the at least three magnetic field sensors can be connected to corresponding inputs of the evaluation device, with each magnetic field sensor in particular having at least one output which can be connected or is connected to a corresponding input of the evaluation device.
- At least a first and a second of the magnetic field sensors are mounted to selectively detect the changes in the field component in the circumferential direction and the at least third Magnetic field sensor is mounted in such a way that it selectively detects changes in the field component in the axial direction.
- the evaluation device advantageously implements at least one first decoder, which can evaluate at least the first and second of the inputs as a quadrature-coded signal in order to quantitatively detect the rotation of the rotating element.
- a signal change at at least a third input can be decoded as a change in position of the push element, in particular also as a rotation of the rotary element.
- the signal changes at the inputs can be processed directly in real time or stored in a FIFO buffer for further processing. With a suitable state machine or memory logic, the movements or states of the actuating device can be mapped or simulated in this way and are available as
- the dosage, injection quantities and injection times in particular the set dose, corrected dose and/or dispensed dose can be calculated with this status information. Errors can also occur at the inputs due to certain signal states or signal sequences
- the evaluation device preferably implements a second decoder which can evaluate the third input and a fourth input as a quadrature-coded signal in order to quantitatively detect the rotation of the rotating element and, together with the first decoder, improve the precision of the detection and discrimination of the change in position of the pushing element.
- Evaluation device have an input which at a signal change the
- Evaluation device wakes up from an energy-saving state and can switch on other parts of the system.
- the magnetic field sensors can preferably be switched on and off via the evaluation device. At least one magnetic field sensor can preferably be varied or switched over by the evaluation device with regard to its sampling rate. For example, in an idle state of the actuating device, only one of the at least 3 magnetic field sensors can be switched on and a low sampling rate can be selected, resulting in low energy consumption in the idle state of the actuating device.
- Suitably high sampling rates for the operating state of the actuating device result from the maximum angular velocities to be expected in the operating state of the actuating device and the number of poles distributed over the circumference of the magnetic element. At least one scan is preferably provided per quadrant of a pole passage.
- Suitably high sampling rates can be, for example, between 1 kHz and 100 kHz or higher, preferably 5 kHz to 20 kHz, for example approximately 10 kHz.
- a first and a second magnetic field sensor are in an unactuated state of the actuating device along a circumferential direction aligned above the magnetic element first axial section and at a first sensor angle relative to the axis of rotation and spaced radially from the magnet element on a sensor plane above the magnet element, with the switching axes of the first and second magnetic field sensors pointing in the circumferential direction or tangentially to the first section or the sensor plane and aligned and rectified or are directed in the opposite direction and/or at least one of the first or second magnetic sensor has an inverted switching characteristic or an inverted output signal.
- the first sensor angle is less than one pole angle or less than one pole angle increased by an integer multiple of a pole angle.
- the magnetic element is preferably positioned with respect to the magnetic field sensors and the switching axes of the first and second magnetic field sensors are directed or their outputs switched in such a way that in the detent position of the rotary element or the magnetic element or when the first and second magnetic field sensors are in a magnetic field with the same polarization one of the two outputs is set and the other of the two outputs is reset.
- a third magnetic field sensor is mounted on the sensor plane when the actuating device is in a non-actuated state along a second axial section that runs in the circumferential direction and is spaced radially from the magnetic element, with this second axial section being offset axially with respect to the first section and/or superimposed on it, with the switching axis of the third Magnetic field sensor has in the axial direction or transversely, in particular is aligned orthogonally to the switching axes of the first and second magnetic field sensors.
- the third magnetic field sensor or the second axial section is positioned relative to the magnet element in such a way that its output is set or can be reset.
- the output signal of the third magnetic field sensor can be used by the evaluation device to detect a change in position of the pusher element and/or to detect a change in angle of the rotary element.
- this third magnetic field sensor can be switched on when the actuating device is in an idle state and a low sampling rate can be selected.
- the evaluation device can thus detect actuation of the actuating device and switch on the rest of the sensor arrangement accordingly and select a sampling rate that is suitably high for an operating state of the actuating device, with which the actuating device switches from the energy-saving idle state to the operational status.
- the third magnetic sensor can detect changes in position and changes in angle without errors and with the shortest possible time delay.
- Appropriately high sampling rates result from the maximum Expected angular velocities of the rotary element in the operating state of the actuating device and the number of poles distributed over the circumference of the magnetic element. At least one scan is preferably provided per quadrant of a pole passage.
- Suitably high sampling rates can be, for example, between 1 kHz to 100 kHz or higher, preferably 5 kHz to 20 kHz, for example approximately 10 kHz.
- the sampling rate can be set lower by at least a factor of 100 for the idle state of the actuating device, resulting in a correspondingly lower energy consumption of the third magnetic field sensor and yet a state change can be detected reliably and quickly enough.
- a fourth magnetic field sensor is mounted on the second section and spaced by a second sensor angle with respect to the axis of rotation to the third magnetic sensor and radially to the magnetic element on the sensor plane above the magnetic element, with the switching axis of the fourth magnetic field sensor pointing in the axial direction or transversely. in particular is aligned orthogonally to the switching axes of the first and second magnetic field sensors, wherein the switching axes of the third and fourth magnetic field sensors are directed in the same direction or in opposite directions and/or one of the third or fourth magnetic sensor has an inverted output.
- the fourth magnetic field sensor is positioned relative to the magnetic element in such a way that its output is set or can be reset.
- the output signal of the third magnetic field sensor can be used by the evaluation device to detect a change in position of the pusher element and/or to detect a change in angle of the rotary element.
- At least one of the first and second magnetic field sensors with at least one of the third and fourth magnetic sensors are preferably mounted on the sensor plane axially in a line or at the same angular position with respect to the axis of rotation.
- the second sensor angle is less than one pole angle or less than one pole angle increased by an integer multiple of a pole angle.
- the magnetic element is preferably positioned with respect to the magnetic field sensors and the switching axes of the third and fourth magnetic field sensors are directed or their outputs switched in such a way that in the latching position of the rotary element or the magnetic element or when the third and fourth magnetic field sensors are in an unequally polarized magnetic field one of the two outputs is set and the other of the two outputs is reset.
- the second sensor angle can have the same value as the first sensor angle. This allows a space-saving design of the sensor arrangement, in particular a surface-saving sensor arrangement on the sensor plane with optimal utilization of the magnetic field and thus an improved signal-to-noise ratio compared to extraneous fields.
- first and third magnetic field sensors can be integrated into a first housing and/or the second and fourth magnetic field sensors can be integrated into a second housing.
- the sensor plane can be flat or curved and/or kinked in sections, in particular bent in the shape of a cylinder jacket. This allows an optimization of the radial position of the magnetic field sensors and thus an optimized utilization of the magnetic field and thus an improved signal-to-noise ratio compared to external fields.
- the senor level can be formed by a printed circuit board and/or conductor foil, which can be connected in particular firmly to the device housing or the sliding element.
- a fifth magnetic field sensor can also be attached along the first and/or second axial section on the sensor plane, with the switching axis of the fifth magnetic field sensor pointing in the axial direction or being aligned transversely, in particular orthogonally, to the switching axes of the first and second magnetic field sensors.
- the fifth magnetic field sensor can be positioned relative to the magnetic element in such a way that its output is set or can be reset.
- the output signal of the fifth magnetic field sensor can be used by the evaluation device to detect a change in position of the pusher element and/or to detect a change in angle of the rotary element.
- this fifth magnetic field sensor can be switched on when the actuating device is in an idle state and a low sampling rate can be selected.
- this fifth magnetic field sensor can be switched on when the actuating device is in an idle state and a low sampling rate can be selected.
- the evaluation device can thus detect actuation of the actuation device and switch on the rest of the sensor arrangement accordingly and select a sampling rate that is suitably high for an operating state of the actuation device, with which the actuation device switches from the energy-saving idle state reached the operating state.
- the fifth magnetic field sensor can be used exclusively for this wake-up function or for an extended plausibility check together with the other magnetic field sensors.
- the actuating device can switch from the operating state to the idle state if the fifth magnetic field sensor and/or other magnetic field sensors from the first to fourth have no signal changes at the respective outputs for a predetermined period of time.
- the measuring arrangement described and its developments according to the invention relatively detect the rotation or the angle of rotation of the rotary element during the setting of the dose and/or during the dispensing of the product. From the logical sequence of the sensed position of the pusher element or the actuation of the push button and the sensed movement of the rotary element, an absolute position of the rotation or the angle of rotation of the rotary element with respect to the device housing can be derived and defined or stored as a reference position. For example, an actuated push button in the absence of rotation of the rotary member for a predetermined time may be interpreted as zero position of the rotary member.
- a reference run for example over a predetermined angle of rotation in a predetermined direction of rotation, may be required, or a predetermined sequence of operations by the user may be required initially or after error states.
- further sensors or limit switches can signal that one or more absolute reference positions have been reached and/or passed, in particular positions of the rotary element with respect to the device housing.
- a development of the invention also includes an administration device for parenteral administration of a medication, comprising: an actuating device according to the invention a piston rod in the form of a threaded rod with a flange a product container held in the device housing, with a drive movement of the piston rod along the longitudinal axis of the device housing being preselectable by the actuating device and /or can be actuated in a controllable and manual manner, for example via a screw drive, or automatically by a motor, in particular an electric motor or a spring motor, as a result of which the medication is expelled from the product container through a needle, for example.
- CHARACTERS a piston rod in the form of a threaded rod with a flange a product container held in the device housing
- FIG. 3 shows components of the actuating device in an exploded view
- Fig. 4 shows the magnetic element
- Fig. 5 shows the in magnetic field strength By (mT) in the circumferential direction as a development.
- Fig. 6 shows the in magnetic field strength Bx (mT) in the axial direction as a development
- Fig. 9 shows the circuit board with magnetic field sensors (seen from the axis of rotation)
- Fig. 10 shows the days of the magnetic element, the sensors and the device housing to each other in the unactuated state
- Fig. 11 shows the days of the magnetic element, the sensors and the device housing to each other in the actuated state
- FIG. 13 shows a flowchart for evaluating the twice quadrature-coded signals in a current state of an AutoPen
- Figures 1 to 3 show an embodiment of the inventive actuating device 1 in an administration device using the example of an AutoPen 2.
- the AutoPen 2 has a with a
- Drug-filled product container 6 on which the device housing 7 is held With a dated With the drive sleeve 35 that can be driven by the spring motor 8, the piston rod with the flange 5 can be advanced through a thread in the distal direction, with a stopper in the product container 6 forcing the medication through a cannula (not shown) in the septum 36 to a rotary element 9 rotating with the drive sleeve 35 on the device housing 7 by a radial stop 37 comes to a standstill.
- the rotating element 9 is provided with a scale that can be read through the scale window 33 .
- the rotary element 9 can be moved away from this stop 37 by a distance proportional to the dose or a rotary angle by turning the rotary knob 34 via a threaded connection with the device housing 7 .
- the rotary movement is transmitted from the rotary knob 34 via the pusher element 11 to the rotary element 9, with the rotary movement tensioning the spring motor 8 acting between the pusher element 11 and the device housing.
- a latching device 13 is able to hold the torque of the spring motor 8 in a non-actuated state of the actuation device in predetermined rotational positions or dose steps.
- the pusher element 11 By pressing the push button 10, the pusher element 11 is moved in the distal direction against the force of the return spring 12, as a result of which the torque of the spring motor 8 is recoupled to the drive sleeve 35 and this can be rotated together with the rotary element. If the push button 10 is released, the pusher element 11 is moved back into its proximal starting position by the return spring 12 and the torque of the spring motor 8 is recoupled to the latching device.
- an administration device in the form of an AutoPen is disclosed in publication WO2009/105910 A1, the entirety of which is incorporated by reference into this description.
- FIG. 4 shows the magnetic element 14 with its axis of rotation 18 which coincides with the initial axis of the rotary element 9, since the magnetic element 14 can be attached coaxially to it by means of positive connections. As a result, the magnetic element follows all movements of the pusher element 11 .
- FIG. 5 shows the magnetic field strength Bx measured in mT in the circumferential direction on a coaxial plane radially spaced apart from the outer surface 16 of the casing as a development. Due to the magnetization also form on the proximal and the distal end face 17 corresponding poles. However, these poles result in a pronounced magnetic field aligned in the axial direction on the said coaxial plane above the magnetic element 14 .
- FIG. 6 shows the magnetic field strength By measured in mT in the axial direction on a coaxial plane radially spaced apart from the outer surface 16 of the jacket as a development.
- the maxima of this field component By are phase-shifted by half a pole angle compared to the maxima of the field component Bx and are each located above the proximal end faces 17.
- FIG. 7 shows the sensor arrangement 20 in the non-actuated state of the embodiment and FIG. 8 shows the same arrangement in the actuated state of the embodiment in a 90° rotated catch section.
- five magnetic field sensors 21 . . . 25 are arranged on a carrier plate or circuit board 29 .
- Embodiments with three or four sensors are readily apparent from the embodiment described here with five sensors and the general description of the invention.
- the magnetic field sensors 21...25 are TMR sensors with bipolar switching characteristics from the RR122 series from the manufacturer RedRock in an EGA housing.
- the magnetic element 14 with its outer casing surface 16 can be rotated about its axis of rotation and moved axially relative to the housing-fixed sensor arrangement 20 without contact.
- the switching axes of the magnetic field sensors 21 and 22, which are also referred to below as sensors A and B, are aligned in such a way that they sense the field component By, in particular switch their output, when the field component By changes polarity due to a relative movement of the magnetic element 14 to the sensor .
- the switching axes of the magnetic field sensors 23 and 24, which are also referred to below as sensors B and C, are aligned in such a way that they sense the field component Bx, in particular switch their output, when the field component Bx changes polarity due to a relative movement of the magnetic element 14 to the sensor. This succeeds if the sensors are arranged on the circuit board 29, for example as shown in FIG.
- the sensors A and B only sense a rotary movement of the rotary element 9 regardless of its axial position.
- the sensors B and C move from the field component Bx over the distal end face 17 of the magnetic element 14 to the field component Bx with the opposite polarity over the proximal end face 17 of the magnetic element 14.
- the Sensors B and C both a rotation and an axial change in position of the rotating element 9.
- Figures 10 shows, as in the embodiment of the inventive actuating device described here, sensors A and B along an axial section 31 and sensors B and C along an axial Section 32 are attached.
- the sensor pairs A and B or C and D are mounted at a sensor angle 26 with respect to the axis of rotation 18 at a radial distance above the lateral surface 16, with the sensor angle 26 being smaller than the pole angle 15.
- the output of sensor A is inverted or is its switching axis Rotated 180° to the switching axis of sensor B. This compensates for the Phase shift by half a pole angle of the field components Bx and By and the sensors A,C and B,C can each be attached to the circuit board in a space-saving manner at the same angular position.
- a fifth magnetic field sensor 25 is attached tangentially somewhat further away from magnetic field element 14 on printed circuit board 29 .
- FIG. 11 shows the arrangement from FIG. 10 in an actuated state of the actuating device.
- FIG. 8 also shows the evaluation device 30 to whose inputs the corresponding outputs of the magnetic field sensors lead.
- the evaluation device 30 can also switch the magnetic field sensors on or off and/or change their sampling rate.
- the evaluation device can also control display elements such as LEDs or a display and/or communicate wirelessly with other systems of an administration system, for example with a remote control or a mobile phone or a system that measures blood sugar and determines an adjusted dosage.
- FIG. 12 shows the state machine for the double quadrature-coded signals from sensors A/B and B/C. With this logic, as shown, the direction of rotation, the relative rotational position, the “pressed” actuation state and error states (not shown) can be mapped by comparing the states or changes in the four signals over an interval of four steps.
- FIG. 13 shows a flowchart for evaluating the twice quadrature-coded signals in a current state of the AutoPen.
- a state machine is implemented to reflect the current pen state of the AutoPen. This state machine does not run in real time.
- There is an event buffer that saves the sensor signals.
- the sensor signals are written to the buffer via an interrupt.
- the buffer is processed cyclically every 10ms, for example. This means that the state machine sequentially processes all sensor signals that were written to the buffer in the last 10ms.
- the state machine is queried for various statuses in the processing cycle and the relevant information is derived.
- QDEC state is updated or the push button status is checked.
- the current state of the pen is described by the step position and whether the push button is pressed or released.
- the status of the quadrature step (QDEC State: 0-3) for the QDEC and ButtonPos signal must always be known.
- the time of the current step (last change step position or button position) must also be saved. The current pen status is always updated as soon as a sensor event is evaluated. If the push button is pressed at a position greater than 0 (possible start of distribution), the StartDeliveryState activated. The current step and time are saved.
- the EndDischargeState and EndDeliveryState are activated.
- the time of the EndDischargeState is when the turning step is reached (last time before the push button is released) and the EndDeliveryState is when the push button is released.
- the injection quantity and injection times can be calculated using the information from the various delivery states.
- the algorithm checks whether there is a sensor error. The quadrature steps can be used to detect errors in the QDEC and push button signals. If an error is detected in the algorithm or for some other reason the last pen state is not correct (e.g. battery discharged), the absolute position of the AutoPen is lost. In order to find the correct position of the algorithm again, the state machine must be reset.
- the user must be involved in order to find the absolute zero position.
- the user must perform an operation that is physically unique and cannot inadvertently be performed otherwise. For example, the user must turn the rotary knob 34 in a decreasing number of steps down to 0 and then press the push button 10 . If this fixed number of steps is counted by the evaluation device, the correct position can be determined and the current status of the AutoPen can be defined as an absolute position or mapped in the algorithm.
- Figure 14 shows a state event diagram for switching on the pen. Waking up from sleep mode is triggered by the fifth magnetic field sensor (start sensor), which measures the same field as the TMR sensor C. If the sensors are started from sleep mode, no step must be lost. This means that when the rotary knob 34 is turned, the first step must be recognized and when the push button 10 is pressed, this must also be recognized in good time. Therefore, for example, a sampling frequency of 500 Hz is required for the start sensor.
- start sensor the fifth magnetic field sensor
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
L'invention concerne un dispositif d'actionnement (1) pour un dispositif d'administration, ainsi qu'un dispositif d'administration pour l'administration parentérale d'un médicament, ledit dispositif d'actionnement comprenant : un élément rotatif (9) pouvant tourner autour de l'axe, d'un angle proportionnel à un volume de dose, par rapport à un boîtier d'appareil (7) ; un élément de poussée (11) mobile par rapport au boîtier d'appareil (7), lequel élément agit sur un mécanisme d'entraînement ; un élément magnétique (14) qui coopère avec l'élément rotatif (9) et/ou l'élément de poussée (11) de façon à suivre le mouvement/les mouvements de celui-ci/ceux-ci par rapport au boîtier d'appareil (7) en particulier ; un système de détection (20) constitué d'au moins trois capteurs de champ magnétique, chacun de ces capteurs de champ magnétique présentant une directivité par rapport à la direction d'une composante de champ magnétique ; et un dispositif d'évaluation (30). Selon l'invention, au moins un premier et un deuxième des capteurs de champ magnétique sont agencés de manière à détecter sélectivement les variations de la composante de champ dans la direction circonférentielle et ledit au moins troisième capteur de champ magnétique est agencé de manière à détecter sélectivement les variations de la composante de champ dans la direction axiale.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21187086.0A EP4122513A1 (fr) | 2021-07-22 | 2021-07-22 | Arrangement d'actionnement amélioré pour un stylo |
PCT/EP2022/063949 WO2023001430A1 (fr) | 2021-07-22 | 2022-05-24 | Dispositif d'actionnement amélioré pour stylo injecteur |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4373551A1 true EP4373551A1 (fr) | 2024-05-29 |
Family
ID=77021213
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21187086.0A Withdrawn EP4122513A1 (fr) | 2021-07-22 | 2021-07-22 | Arrangement d'actionnement amélioré pour un stylo |
EP22730232.0A Pending EP4373551A1 (fr) | 2021-07-22 | 2022-05-24 | Dispositif d'actionnement amélioré pour stylo injecteur |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21187086.0A Withdrawn EP4122513A1 (fr) | 2021-07-22 | 2021-07-22 | Arrangement d'actionnement amélioré pour un stylo |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP4122513A1 (fr) |
CN (1) | CN117677416A (fr) |
WO (1) | WO2023001430A1 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008011886A1 (de) | 2008-02-29 | 2009-09-24 | Tecpharma Licensing Ag | Injektionsvorrichtung mit einer Einrichtung zur Verhinderung von Fehlausschüttungen |
US10010678B2 (en) * | 2010-03-31 | 2018-07-03 | Emperra Gmbh E-Health Technologies | Assembly to administer insulin from a cartridge |
CA3051323A1 (fr) * | 2017-01-25 | 2018-08-02 | Lionel ALDON | Systeme de commande de dose pour dispositifs d'administration de medicaments injectables et procedes d'utilisation associes |
JP7084412B2 (ja) | 2017-02-28 | 2022-06-14 | イーライ リリー アンド カンパニー | 薬物送達装置のための用量検出および薬物識別 |
WO2019001919A1 (fr) | 2017-06-27 | 2019-01-03 | Novo Nordisk A/S | Dispositif accessoire ayant un élément d'appariement |
SG10201801940VA (en) | 2018-03-08 | 2019-10-30 | Bosch Gmbh Robert | A drug delivery system |
EP3545995A1 (fr) * | 2018-03-28 | 2019-10-02 | Sanofi | Dispositif d'injection |
-
2021
- 2021-07-22 EP EP21187086.0A patent/EP4122513A1/fr not_active Withdrawn
-
2022
- 2022-05-24 WO PCT/EP2022/063949 patent/WO2023001430A1/fr active Application Filing
- 2022-05-24 CN CN202280051402.7A patent/CN117677416A/zh active Pending
- 2022-05-24 EP EP22730232.0A patent/EP4373551A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4122513A1 (fr) | 2023-01-25 |
WO2023001430A1 (fr) | 2023-01-26 |
CN117677416A (zh) | 2024-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10330984B4 (de) | Injektionsgerät mit Positionssensor | |
EP2774641B1 (fr) | Système d'administration d'insuline à partir d'une cartouche | |
US9669168B2 (en) | Dose setting mechanism for an injection device and having a preset feature | |
US7511480B2 (en) | Non-contact scanning using magneto-resistive sensor | |
CN107405453B (zh) | 用于注射装置的传感器组合体 | |
AU2007301890B2 (en) | An injection device with electronic detecting means | |
EP1432465B1 (fr) | Identification d'ampoule | |
CN110337311A (zh) | 用于药物递送装置的剂量检测和药物识别 | |
EP3359229B1 (fr) | Injecteur avec circuit electrique destructible par suite d'usage | |
DE60034524T2 (de) | Elektronischer Injektionsstift mit Multifunktionsstellvorrichtung | |
WO2014128156A1 (fr) | Module capteur rotatif à commutateur axial | |
EP2275158A3 (fr) | Appareil injecteur de médication avec ensemble d'entraînement qui facilite le réarmement | |
KR102606947B1 (ko) | 주입 가능한-약물 전달 디바이스들을 위한 도즈 제어 디바이스 | |
CN110062641A (zh) | 注射装置 | |
EP4373551A1 (fr) | Dispositif d'actionnement amélioré pour stylo injecteur | |
JP2022512884A (ja) | 特徴をサンプリングするセンサを有する薬剤送達アセンブリ | |
DE102015220905A1 (de) | Fluidabgabevorrichtung, Verfahren zum Betreiben einer Fluidabgabevorrichtung und Steuergerät | |
DE102016208635A1 (de) | Verfahren und Vorrichtung zum Bestimmen eines Injektionsvorgangs eines Injektionsgeräts und Injektionsgerät zum Injizieren von Fluid | |
WO2017153479A1 (fr) | Dispositif de détection pour détecter une valeur représentant une dose d'un appareil de dosage et procédé de fonctionnement du dispositif de détection | |
WO2018137929A1 (fr) | Dispositif pour l'injection sous-cutanée d'un principe actif liquide et procédé pour détecter une quantité administrée de principe actif liquide | |
WO2017011926A1 (fr) | Dispositif d'injection comprenant des éléments d'accouplement | |
DE102016203902A1 (de) | Erfassungseinrichtung zum Erfassen eines eine Dosis eines Dosiergeräts repräsentierenden Werts und Verfahren zum Betreiben desselben | |
WO2023046741A1 (fr) | Appareil d'injection doté d'un capuchon | |
EP4164715A1 (fr) | Détermination de l'état d'utilisation d'un dispositif pour l'administration unique d'un médicament | |
CN117980021A (zh) | 对药物递送装置或药物递送附加装置的传感器的至少一个阈值的调节 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20240222 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |